[1]
Mykhaloiko, I.S., Yatsyshyn, R.I., Cherniuk, N.V., Kaminskyi, V.Y. and Humeniuk, M.Y. 2025. Apixaban in glomerulonephritis with nephrotic syndrome: thromboprophylaxis and pleiotropic effects in a prospective cohort study. Modern medical technology. 17, 3 (Sep. 2025), 188–194. DOI:https://doi.org/10.14739/mmt.2025.3.335542.